$21.82
0[0.00%]
At close: Apr 17
$21.82
0[0.00%]
PreMarket: 4:00PM EDT
Bicycle Therapeutics
(NASDAQ:BCYC)Latest News for Bicycle Therapeutics Stock (NASDAQ:BCYC)
Bicycle Therapeutics Stock (NASDAQ: BCYC)
Categories: All
Wednesday, April 10, 2024
Wednesday, February 21, 2024
- Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For WednesdayAvi Kapoor - Feb 21, 2024, 1:45PM
- Canaccord Genuity Reiterates Buy on Bicycle Therapeutics, Maintains $60 Price TargetBenzinga Newsdesk - Feb 21, 2024, 8:57AM
- The Analyst Landscape: 4 Takes On Bicycle TherapeuticsBenzinga Insights - Feb 21, 2024, 8:00AM
- HC Wainwright & Co. Maintains Buy on Bicycle Therapeutics, Lowers Price Target to $55Benzinga Newsdesk - Feb 21, 2024, 7:04AM
- Needham Reiterates Buy on Bicycle Therapeutics, Maintains $43 Price TargetBenzinga Newsdesk - Feb 21, 2024, 5:34AM
Tuesday, February 20, 2024
Tuesday, February 13, 2024
Wednesday, December 20, 2023
Friday, December 15, 2023
Thursday, December 14, 2023
- Bicycle Therapeutics shares are trading lower. The company announced data updates for BT8009, BT7480 and BT5528.Benzinga Newsdesk - Dec 14, 2023, 11:48AM
- Bicycle Therapeutics Provides Data Updates For BT8009, BT7480 And BT5528 Programs, Strategy Overview at First R&D DayBenzinga Newsdesk - Dec 14, 2023, 7:11AM
Thursday, November 30, 2023
Thursday, November 16, 2023
Wednesday, November 08, 2023
Friday, November 03, 2023
Thursday, November 02, 2023
Tuesday, September 12, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023Benzinga Insights - Sep 12, 2023, 11:00AM
- B. Riley Securities Upgrades Bicycle Therapeutics to Buy, Announces $33 Price TargetBenzinga Newsdesk - Sep 12, 2023, 9:54AM
- Cantor Fitzgerald Reiterates Overweight on Bicycle Therapeutics, Maintains $65 Price TargetBenzinga Newsdesk - Sep 12, 2023, 9:04AM
- JMP Securities Reiterates Market Outperform on Bicycle Therapeutics, Maintains $44 Price TargetBenzinga Newsdesk - Sep 12, 2023, 8:04AM
- Needham Reiterates Buy on Bicycle Therapeutics, Maintains $46 Price TargetBenzinga Newsdesk - Sep 12, 2023, 5:25AM
Monday, September 11, 2023
- Bicycle Therapeutics shares are trading higher after the company announced an expedited development plan for BT8009. B. Riley Securities upgraded the stock from Neutral to Buy.Bill Haddad - Sep 11, 2023, 2:24PM
- B. Riley Securities Upgrades Bicycle Therapeutics to Buy, Maintains Price Target to $33Benzinga Newsdesk - Sep 11, 2023, 1:58PM
- Bicycle Therapeutics Announced To Proceed With Its Plan To Expedite The Development Of Bt8009 For Metastatic Bladder (Urothelial) Cancer Following Recent Discussions With The FDA, The Study Is Expected To Start In Q1 2024Benzinga Newsdesk - Sep 11, 2023, 7:10AM
Thursday, September 07, 2023
Friday, August 04, 2023
- Morgan Stanley Reiterates Equal-Weight on Bicycle Therapeutics, Maintains $42 Price TargetBenzinga Newsdesk - Aug 4, 2023, 12:46PM
- Expert Ratings for Bicycle TherapeuticsBenzinga Insights - Aug 4, 2023, 9:00AM
- JMP Securities Maintains Outperform on Bicycle Therapeutics, Lowers Price Target to $44Benzinga Newsdesk - Aug 4, 2023, 7:21AM
- HC Wainwright & Co. Reiterates Buy on Bicycle Therapeutics, Maintains $57 Price TargetBenzinga Newsdesk - Aug 4, 2023, 6:23AM
- Needham Maintains Buy on Bicycle Therapeutics, Lowers Price Target to $46Benzinga Newsdesk - Aug 4, 2023, 5:25AM
Thursday, August 03, 2023
- EF Hutton Reiterates Buy on Bicycle Therapeutics, Maintains $50 Price TargetBenzinga Newsdesk - Aug 3, 2023, 1:38PM
- Bicycle Therapeutics' Q2 Cash And Cash Equivalents Were $340.4MBenzinga Newsdesk - Aug 3, 2023, 7:18AM
- Bicycle Therapeutics Q2 EPS $(1.41) Misses $(1.29) Estimate, Sales $11.40M Beat $4.58M EstimateBenzinga Newsdesk - Aug 3, 2023, 7:17AM
Thursday, July 13, 2023
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jul 13, 2023, 1:37PM
- Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On ThursdayLisa Levin - Jul 13, 2023, 10:59AM
- Bicycle Therapeutics Priced Its Public Offering Of 9.4M American Depositary Shares, Each Representing One Ordinary Share, At $21.25 Per Share, For Gross Proceeds Of Approximately $200MBenzinga Newsdesk - Jul 13, 2023, 4:48AM